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Abstract. Epidemiological data suggests that there are func-
tional links between bronchial asthma and lung carcinogenesis. 
Bronchial fibroblasts serve a prominent role in the asthmatic 
process; however, their involvement in lung cancer progression 
remains unaddressed. To estimate the effect of the asthmatic 
microenvironment on the invasiveness of lung cancer cells, 
the present study compared the behavior of human non‑small 
cell lung cancer A549 cells exposed to the signals from human 
bronchial fibroblasts (HBFs) derived from non-asthmatic 
donors (NA HBFs) and from asthmatic patients (AS HBFs). 
NA HBFs did not significantly affect A549 motility, whereas 
AS HBFs and the media conditioned with AS HBF/A549 
co-cultures increased Snail-1/connexin43 expression and 
motility of A549 cells. In contrast to NA HBFs, which formed 
A549-impenetrable lateral barriers, α-SMA+ AS HBFs actively 
infiltrated A549 monolayers and secreted chemotactic factors 
that arrested A549 cells within AS HBF/A549 contact zone. 
However, small sub‑populations of A549 cells could release 
from this arrest and colonize distant regions of AS HBF mono-
layers. These data indicated that the interactions between lung 
cancer cells and HBFs in asthmatic bronchi may facilitate the 
colonization of lung tumors by fibroblasts. It further stabi-
lizes the tumor microenvironment and potentially facilitates 
collective colonization of novel bronchial loci by cancer cells. 
Potential mechanistic links between the asthmatic process and 
lung cancer progression suggest that bronchial asthma should 
be included in the list of potential prognostic markers for lung 
cancer therapy.
Introduction
Bronchial asthma is one of the most common chronic 
diseases throughout the world and its rate of prevalence has 
continuously increased over the last decades (1). During 
the asthmatic process, epithelial damage is followed by 
the thickening of asthmatic bronchial walls, which is 
mechanistically linked to the local inflammation and the 
activation of bronchial fibroblasts (2-4). Local inflammation 
induces the differentiation of bronchial fibroblasts into 
α-smooth muscle actin (α-SMA)positive myofibroblasts 
and increases their longevity (5) through paracrine (for 
example TGFβ-dependent) and cell adhesion-dependent 
mechanisms (3,6,7). A high extracellular matrix-producing 
activity and contractility of myofibroblasts (8) participates 
in bronchial fibrosis, fibrotic remodeling of airways and lung 
parenchymal compartments, and a pulmonary dysfunction. 
The asthmatic process may also facilitate the progression of 
other chronic lung diseases. Importantly, epidemiologic data 
show the correlation between the incidence of asthma and lung 
cancer in developed countries (9).
Chronic inflammation and tissue fibrosis have long been 
considered to induce phenotypic shifts in cancer cells, such 
as epithelial-mesenchymal transition (EMT), which accounts 
for the formation of cancer invasive front. In particular, 
cancer-associated fibroblasts (CAFs) participate in cancer 
progression and metastasis (10,11). During lung cancer progres-
sion, the connective tissue of bronchial walls provides the 
scaffold for developing tumors, forms tissue barriers against 
immune responses of the host and/or constitutes the routes for 
the invasion of cancer cells (12). Accordingly, the activation of 
fibroblasts/myofibroblasts, which is characteristic for the asth-
matic process, may facilitate lung cancer progression. However, 
the contribution of asthmatic bronchial fibroblasts in systemic 
dissemination of lung cancer cells remains unaddressed. We 
have previously shown that human bronchial fibroblasts (HBFs) 
derived from asthmatic patients (AS HBFs) display relatively 
high susceptibility to TGFβ‑inducible fibroblast‑myofibroblast 
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transition [FMT; (13-15)]. These heritable pro‑fibrotic proper-
ties of AS HBFs prompted us to hypothesize that AS HBFs may 
contribute to lung carcinogenesis. To elucidate the links between 
their function and the progression of lung cancer, we compared 
the behavior of human non‑small cell lung cancer A549 cells 
exposed to the signals from monolayers of AS HBFs and from 
HBFs derived from non‑asthmatic (NA) donors.
Materials and methods
Isolation and propagation of primary HBFs. Primary HBFs 
were isolated from bronchial biopsies derived from i) the indi-
viduals in whom diagnostic bronchoscopy ruled out any serious 
airway pathology, i.e., asthma, chronic inflammatory lung 
disease or cancer (NA group; N=5, averaged age, 57.4±9.9 years; 
FEV1(%)=101.83±14.7) and ii) from the patients with moderate 
asthma (AS group; N=5; age, 39±17.6 years; mean duration of 
asthma=16.7±12.2 years; FEV1(%)=48.75±0.86). Patients were 
treated in the Department of Medicine of Jagiellonian University 
(Kraków, Poland) and were in a stable clinical condition. AS 
HBF lineages were derived from a 38 years old man/66 years 
old woman (asthma duration=10/30 years; FEV1(%)=35/52.5). 
These lineages displayed a considerably higher pro-fibrotic 
potential than their non‑asthmatic counterparts; however, no 
relationship between their phenotypic properties and the age/sex 
of the donors, or with the development of asthma severity was 
observed (6,13-15). The present study was approved by 
the Jagiellonian University's Ethics Committee (decision 
no. 122.6120.69.2015) on the basis of written informed consent 
for the use of HBF cell lines in basic research, which had previ-
ously been obtained from all donors. For endpoint experiments, 
HBFs were harvested between the 5th and 15th passage after the 
establishment of primary cultures.
Co‑cultures of A549 cells with HBFs. HBFs were 
propagated in DMEM supplemented with a 10% FCS and 
antibiotic-antimycotic cocktail (both Sigma-Aldrich; Merck 
KGaA, Darmstadt, Germany) whereas human lung carcinoma 
A549 cells (ECACC 86012804) were cultured in RPMI-
1640 medium (Sigma-Aldrich; Merck KGaA) with the same 
supplements. Cells were incubated in a humidified atmosphere 
with 5% CO2 at 37˚C to reach 80% confluence. For ‘open’ 
co‑cultures with HBFs, A549 cells were seeded on coverslips 
at the density of 104 cells/cm2 together with HBFs (seeded at 
103 cells/cm2) and incubated for 48 h in DMEM supplemented 
with a 10% FCS. Alternatively, A549 and HBFs (NA or AS) were 
seeded into the chambers of Ibidi µ-Slide 2 Well Co-Culture 
dish (81806; Ibidi GmbH, Munich, Germany) for 48 h in 2 ml 
of the same medium (i.e., in the conditions allowing only for 
exchange of the medium between the chambers; ‘isolated’ 
co-cultures). Furthermore, A549 cells and HBFs were seeded in 
the chambers of 2 well silicone inserts with a defined cell free 
gap (81176; Ibidi GmbH) cultured for 6 h and the next 42 h after 
the removal of silicone insert (‘confronted’ co-cultures). Media 
conditioned by HBFs and 3 variants of HBF/A549 co-cultures 
were collected and kept in ‑80˚C for endpoint experiments. 
For the estimation of the effect of A549/HBF ‘secretomes’ on 
A549 motility/transmigration, the cells were incubated in the 
presence of the mixture of relevant conditioned medium/fresh 
medium (1:1 v/v). For 2D invasion assays A549 cells and HBFs 
were seeded in the chambers of 2-well silicone inserts (81176; 
Ibidi GmbH). The cells were cultured to monolayers (48 h) and 
allowed to migrate for the next 48 h after removal of the silicone 
insert. Then, the cells were fixed and stained (see below) to 
estimate the effect of paracrine/juxtacrine signaling between 
A549 cells and HBFs on A549 invasive front formation.
Cell migration and transmigration tests. Movement of A549 
cells in co-cultures with HBFs and in the conditioned media 
was registered using Leica DMI6000B time‑lapse video-
microscopy system (Leica Microsystems GmbH, Wetzlar, 
Germany) equipped with a temperature/CO2 chamber and 
Integrated Modulation Contrast (IMC) optics. Sequences of 
cell centroid positions were recorded at 300 s time intervals 
for 6 h using a dry 20x, NA‑0.75 objective (16). The averaged 
total length of cell trajectory (i.e., the ‘Distance’ covered by 
the cells during the registration time; µm) and the total length 
of cell displacement (‘Displacement’, i.e., the distance from 
the starting point directly to the cell's final position; µm) were 
quantified from cell trajectories with the purpose‑designed 
Hiro program. The averaged velocity of cell motility (VCM) 
and velocity of cell displacement (VCD) were defined as 
the averaged ‘Distance’/time of registration and averaged 
‘Displacement’/time of registration, respectively. Cell trajecto-
ries (N>50) from no less than three independent experiments 
(N>3) were taken for the estimation of statistical significance. 
For transmigration assays, A549 cells were seeded into 
chambers containing microporous membranes (pore diameter 
8 µm; membrane diameter 6.5 mm; 2422; Corning, NY, USA) 
at the density of 300 cells/mm2. The inserts were placed in 
the wells of 24-well plates filled with control, HBF and 
HBF/A549‑conditioned media (1:1 v/v with a fresh medium) 
and the cells were allowed to transmigrate for 48 h. The 
numbers of the transmigrated cells were determined with 
Coulter counter after the next 48 h (17).
Immunofluorescence and cytofluorimetry. For the immuno-
fluorescence analyses of Snail‑1/α-SMA/Cx43, the cells were 
fixed in MetOH/Acetone (7:3) solution for 10 min. in ‑20˚C. 
The fixed cells were incubated in 3% BSA solution and incu-
bated with the primary antibodies (mouse anti-α-SMA IgG; 
Sigma-Aldrich; Merck KGaA; A2547; 1:300); rabbit anti-Snail-1 
antibody (SAB 4504319; 1:100) and mouse anti-Cx43 IgM 
(both Sigma-Aldrich; Merck KGaA; C8093; 1:300) for 1 h. 
Then, the cells were incubated with the secondary antibody 
[Alexa Fluor® 647‑conjugated goat anti-mouse IgG (A21235), 
Alexa Fluor® 488‑conjugated goat anti-rabbit IgG (A11008) or 
Alexa Fluor® 546‑conjugated goat anti‑mouse IgM (A21045); 
all 1:500; Thermo Fisher Scientific, Inc., Waltham, MA, USA]. 
Image acquisition was performed with Leica DMI6000B 
microscope (DMI7000 version; Leica Microsystems GmbH) 
equipped with the Nomarski Interference Contrast (DIC) 
module. Cytofluorimetric analyses were performed with LasX 
software (Leica Microsystems GmbH) and ImageJ freeware 
(National Institutes of Health, Bethesda, MD, USA), respec-
tively (17) to generate histograms that show the co-localization 
of immunofluorescence signals along the scan line.
Statistical analysis. Statistical analysis was performed using 
one‑way analysis of variance followed by Tukey's honestly 
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significant difference post-hoc and Statistica Data Miner 
Software version 13 (StatSoft, Inc., Tulsa, OK, USA). Data are 
expressed as the mean ± standard error of the mean. *P<0.05 
was considered to indicate a statistically significant difference.
Results
AS HBFs stimulate the invasive behavior of A549 cells. 
To estimate how asthmatic bronchial microenvironment 
participates in lung cancer progression, we used an 
experimental approach based on the ‘open’ co-cultures 
of non-small cell lung cancer (A549) cells with bronchial 
fibroblasts derived from 2 asthmatic patients (AS HBFs). An 
activation of A549 cells in the proximity of both AS HBF 
lineages was illustrated by the induction of their motility in 
the co-cultures (Fig. 1A). Interestingly, AS1 HBFs activated 
A549 cell locomotion without any considerable effect on 
its efficiency (the cell displacement), whereas the increased 
velocity of A549 displacement was observed in the proximity 
of AS2 HBFs (Fig. 1C; cf. Table I). Differences in A549 cell 
reactions to the signals from the analyzed AS HBF lineages 
were accompanied by different behavior of AS and NA HBFs 
in the proximity of A549 cells. AS HBFs of both lineages 
were dispersed among A549 cells, whereas NA HBFs formed 
compact multicellular clusters (Fig. 1B) and only slightly 
affected the motility of A549 cells (Fig. 1D). Pictures in Fig. 1B 
illustrate the morphology of NA and AS HBFs in confluent 
co-cultures with A549 cells. Some differences in the HBF 
density result from more efficient spreading of the fibroblasts 
from AS group. These observations suggest that HBFs from 
asthmatic bronchi can differentially activate lung cancer cells 
via paracrine and/or juxtacrine signaling pathways.
AS HBFs induce the motility of A549 cells via contact‑modulated 
paracrine signaling. Numerous signaling systems have been 
implicated in the regulation of cancer cell motility by CAFs (18). 
In our hands, media conditioned by both analyzed AS HBF 
lineages augmented the motility of A549 cells (Fig. 2A). 
A549 displaced more efficiently in the presence of AS1 
HBF-conditioned medium, whereas AS2 HBF secretome had no 
significant effects on the efficiency of A549 displacement, even 
though it induced the movement of A549 cells (Fig. 2C; Table I). 
An induction of A549 displacement was also observed in the 
presence of the media conditioned by AS HBF/A549 cells 
co-cultured in the conditions allowing for their mutual paracrine 
(i.e., in ‘isolated’ co-cultures) and paracrine/juxtacrine interac-
tions (i.e., in ‘confronted’ co-cultures). Generally, this effect was 
stronger than in the presence of the media conditioned by AS 
HBFs and ‘open’ AS HBF/A549 co‑cultures; however certain 
differences were seen in A549 responses to AS1 HBF/A549 and 
AS2 HBF/A549 secretome (Fig. 2C). We also observed nuclear 
accumulation of Snail-1 and Cx43 up-regulation in A549 cells 
cultured in the media from the ‘isolated’ co-cultures (Fig. 2B). 
On the other hand, NA HBF/A549 secretomes displayed a 
considerably lower pro‑invasive activity regardless of the culture 
conditions (Fig. 2D; Table I). Collectively, these data show that 
paracrine/juxtacrine communication between A549 cells and 
AS HBFs affects their secretome, thus regulating A549 invasive 
behavior.
AS HBFs selectively modulate the invasion of A549 
cells. To further estimate the biological significance of 
juxtacrine/paracrine loops between bronchial fibroblasts and 
lung cancer cells, we analyzed the behavior of HBFs and A549 
cells at the confrontation front of their monolayers. When 
confronted with A549 cells, NA HBFs formed lateral barrier 
structures, which were similar to these seen in the ‘open’ 
co-cultures (see Fig. 1C) and remained impenetrable to A549 
cells (Fig. 3A). In turn we observed α-SMA up-regulation in 
AS HBFs. Concomitantly, α-SMApositive AS HBFs efficiently 
Figure 1. HBFs stimulate the invasive behavior of A549 cells. (A) A549 cells and AS HBFs were seeded at a density of 104 and 103 cells/cm2, respectively, and 
were incubated for 48 h in Dulbecco's modified Eagle's medium supplemented with a 10% fetal calf serum. The motility of A549 cells was estimated with 
time‑lapse videomicroscopy and (C) its parameters were quantified in comparison to control A549 cells. (B) A549/HBF co‑cultures were established as in 
(A) and cell morphology was visualized with NIC microscopy. Scale bars, 100 µm. (D) The motility of A549 cells in co‑cultures with NA HBFs estimated by 
time‑lapse videomicroscopy as in (A). At least 50 cell trajectories were drawn for each condition and presented in correlative plots. Dot‑plots and column charts 
present movement parameters at the single cell and population level, respectively. Data are representative of 3 independent experiments. *P<0.05 vs. A549. 
Data are presented as the mean ± standard error of the mean. Note that the disruption and penetration of A549 cell monolayers by AS HBFs is correlated with 
the induction of A549 motility. HBFs, human bronchial fibroblasts; AS, asthmatic donors; NA, non‑asthmatic donors; VCM, velocity of cell motility; VCD, 
velocity of cell displacement; NIC, Nomarski Interference Contrast.
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infiltrated A549 monolayers, which was accompanied by the 
remodeling of interfaces between AS HBF and A549 monolayers. 
Noteworthy, α‑SMA expression was also observed in A549 cells 
and in AS HBFs exposed to AS HBF/A549 conditioned media 
(Fig. 3B). On the other hand, we did not observe any collective 
infiltration of AS HBF continua by A549 cells, even though 
Snail-1 was accumulated in A549 nuclei throughout the contact 
zone with AS HBFs (Fig. 3C). Instead, small and scattered 
clusters of Cx43positive A549 cells were observed within AS HBF 
continua (Fig. 3A and B; inserts). This was accompanied by a 
relatively high chemotactic response of A549 cells to the media 
conditioned by ‘open’ A549/AS HBF co-cultures (Fig. 3D). These 
data indicate that juxtacrine/paracrine signaling in A549/HBF 
co‑cultures facilitates the activation of AS HBFs and secretion of 
chemotactic factors, which arrest lung cancer cells in A549/HBF 
confrontation front. Small sub-populations of resistant cells 
can overcome this arrest and migrate through cell‑penetrable 
interfaces between AS HBF and A549 monolayers.
Discussion
The contribution of the tissue microenvironment to the cancer 
disease is exemplified by the involvement of endothelial, 
immune and connective tissue cells in cancer promotion and 
progression. These processes are regulated by paracrine and 
juxtacrine loops that are locally established between cancer 
and stromal cells (19-21). In particular, the interactions 
between cancer cells and CAFs participate in the formation 
of the scaffolds that sustain the structure of tumor‑protective 
tissue barriers (22,23). CAFs can also generate signals crucial 
for the microevolution and expansion of invasive cancer cell 
sub‑populations. Our study is the first to suggest the functional 
links between lung cancer progression and pro‑fibrotic proper-
ties of fibroblasts that reside in asthmatic bronchi.
We have previously shown a high pro‑fibrotic activity of 
the fibroblasts derived from asthmatic bronchi. In response to 
TGFβ, AS HBFs undergo fibroblast‑myofibroblast‑transition 
(FMT), which facilitates bronchial remodeling and asthmatic 
process in vivo (13,15,24). Here we have shown that AS HBFs 
react to A549 cells and to AS HBF/A549 secretome with 
α‑SMA/Cx43 up‑regulation, which is a sign of their myofi-
broblastic differentiation (15). Concomitantly, Snail-1/Cx43 
activation and the induction of A549 cell motility was detected 
in A549 cells exposed to direct contacts with AS HBFs 
and to AS HBF/A549 secretome. Snail-1/Cx43-dependent 
axis has been suggested to regulate the invasiveness of the 
prostate (17,25) and lung cancer cells (26). Therefore, these 
observations confirm that paracrine/juxtacrine interactions 
Table I. Summary of the quantitative data evaluating the effect of HBFs on A549 cell motility.
Variant Distance ± SEM (µm) Displacement ± SEM (µm/min) CME ± SEM (%)
Control (A549) 268.797±9.291 18.611±1.376 6.880±0.723
+CM HBFs   
  NA1 447.073±13.836a  28.226±2.796 7.582±0.900
  NA2 417.337±13.776a  20.420±3.197a 5.632±0.844
  AS1 325.099±9.794 34.768±2.932a  13.805±1.539a
  AS2 584.146±17.543a 21.884±2.074 5.010±0.768
+CM HBFs isolated   
  NA1 316.663±11.869 27.537±2.269 11.206±1.205
  NA2 380.407±14.506a  24.401±2.031 8.418±0.947
  AS1 416.148±12.914a 36.541±2.694a  10.534±1.041
  AS2 422.320±16.828a 41.202±3.436a  12.924±1.446
+CM A549/HBFs CONFRONTED   
  NA1 325.500±11.423 22.790±2.187 7.905±0.851
  NA2 463.809±15.997a  25.114±2.320 6.997±0.853
  AS1 387.730±14.364a 44.422±3.688a  15.099±1.617a
  AS2 435.521±12.779a 33.665±3.002a  9.635±1.177
A549/HBFs CO-culture   
  NA1 234.485±6.225 19.744±1.888 9.666±1.117
  NA2 239.516±8.294 15.692±1.574 7.505±0.767
  AS1 383.326±10.824a 19.198±1.381 5.556±0.528
  AS2 265.195±9.993 32.397±2.353a  15.779±1.665a
Distance is defined as the total length of cell trajectory (6 h); cell displacement is defined as the total length of cell displacement from the 
starting point to the final cell position/time of recording (6 h); CME is the ratio of cell displacement to cell trajectory length, which was 
calculated as: (Total length of cell displacement/total length of cell trajectory) x 100. CME would equal 100 for cells moving persistently 
along one straight line in one direction and 0 for a random movement. aP<0.05 vs. control. SEM, standard error of the mean; CME, Coefficient 
of Movement Efficiency; CM, conditional medium; HBFs, human bronchial fibroblasts; AS, asthmatic donors; NA, non‑asthmatic donors.
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between asthmatic CAFs and lung cancer cells contribute to the 
phenotypic dynamics at the interface between the cancerous 
tissue and bronchial stroma. The lack of the corresponding 
activation of NA HBFs and A549 cells in NA HBF/A549 
co-cultures suggests the absence of the corresponding para-
crine loops in non-asthmatic bronchi.
On the other hand, we noticed the differences in the quan-
tity of motility-related A549 reactions to AS1 and AS2 HBFs. 
They can be ascribed to the apparent phenotypic differences 
between the discrete AS HBF lineages. In general, AS HBFs 
lineages derived from different patients display a very high 
pro‑fibrotic potential in comparison to their counterparts from 
NA donors (6,13-15). However, they differ in morphology, a 
proliferation rate, susceptibility to TGFβ, and the efficiency of 
TGFβ-induced FMT. This is not surprising, since the pheno-
typic characteristics of HBF lineages can be interpreted as 
the snapshots of the resident cells' characteristics, which may 
differ between the patients. A certain diversity of A549 reac-
tions to AS1 and AS2 HBFs may thus illustrate a differential 
contribution of HBF lineages to the lung cancer microenviron-
ment in vivo. Collectively, these data indicate that the asthmatic 
process may constitute a local bronchial microenvironment 
that promotes lung cancer remodeling and progression.
The potential significance of AS HBFs for cancer 
development in vivo was also emphasized by their invasive 
behavior in the proximity of A549 cells. AS HBFs failed 
to form lateral barrier structures that are characteristic for 
their non‑asthmatic counterparts; instead, they collectively 
infiltrated A549 monolayers (4). On the other hand, we 
observed a relatively low translocation of A549 in co‑cultures 
with AS HBFs and the lack of collective infiltration of AS 
HBF continua by A549 cells. This somewhat unexpected 
observation can be interpreted in terms of a strong 
chemotactic activity of the factors preferentially secreted by 
AS HBFs/A549 cells within the contact zone. It suggests that 
combined juxtacrine/paracrine interactions between AS HBFs 
and A549 cells counteract their chemodynamic effect on A549 
cells. These observations also confirm the modulating effect 
of juxtacrine signaling on the quality/quantity of integrated 
AS HBF/A549 secretome. Noteworthy, scattered A549 cells 
were seen within AS HBF monolayers beyond AS HBFs/A549 
confrontation zones. This is consistent with our previous report 
on the heterogeneity of A549 invasive potential (26). It shows 
that small sub-populations of chemotaxis-resistant A549 cells 
can still colonize more distant regions of asthmatic bronchi.
Epidemiologic association between asthma and the risk 
of lung cancer formation is a controversial matter (9,27). For 
the first time we have shown that the microenvironment of 
asthmatic airways promotes the establishment of signaling 
loops between bronchial fibroblasts and lung cancer cells. 
This observation remains in concordance with the reports on 
intercellular signaling between cancer cells and CAFs during 
cancer progression (18,28,29). Accordingly, the infiltration 
of lung tumors by CAFs, which is induced by paracrine 
loops between asthmatic CAFs and lung cancer cells, may 
stabilize the structure of lung tumors. Chemotactic arrest of 
lung cancer cells, enforced by the gradients of chemotactic 
signals generated at the contact zone between tumor cell mass 
and stroma, can further strengthen this effect. Concomitant 
activation of cancer cells may stimulate local remodeling of 
cancerous tissue. However, small sub‑populations of invasive, 
chemotaxis-resistant lung cancer cells, which penetrate the 
Figure 2. AS HBFs induce the motility of A549 cells via contact‑modulated paracrine signaling. (A) A549 cells were cultivated in the media conditioned by AS2 
HBFs (left), ‘separated’ (middle) and ‘confronted’ AS HBF/A549 co‑cultures (1:1 v/v with fresh medium) for 48 h and (C) the parameters of their motility were 
analyzed by time‑lapse videomicroscopy in comparison to A549 motility in control conditions and in ‘open’ AS HBF/A549 co‑cultures. (B) A549 cells were 
cultivated in the media conditioned by ‘separated’ co‑cultures of A549 with AS and NA HBFs (1:1 v/v with fresh medium) for 48 h. Intracellular localization of 
Snail‑1/Cx43 and co‑localization of Snail‑1/DNA was visualized with immunofluorescence and cytofluorimetry, respectively (left axes/blue line: DNA; right 
axes/green line: Snail‑1). Scale bar, 50 µm; magnification, x400. (D) The motility of A549 cells in the presence of the media conditioned by NA HBFs (left), 
‘separated’ (middle) and ‘confronted’ NA HBF/A549 co‑cultures (1:1 v/v with fresh medium) was analyzed as in (A). Data are presented as the mean ± standard 
error of the mean of 3 independent experiments. *P<0.05 vs. A549. Note the mobilization of A549 in the presence of AS HBF/A549‑conditioned media, which 
was correlated with Snail‑1/Cx43 activation. HBFs, human bronchial fibroblasts; AS, asthmatic donors; NA, non‑asthmatic donors; VCD, velocity of cell 
displacement; Cx43, connexin43; CM, conditional media.
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compromised stromal barriers, can form new chemotactic loci 
and prompt collective invasion of other cancer cells. Further 
research based on the more comprehensive spectrum of lung 
cancer cell lineages is necessary to verify this hypothesis, 
to elucidate a biological significance of the expression and 
nuclear accumulation of α-SMA in A549 cells and to identify 
the elements of AS HBF/A549 secretome, which are respon-
sible for lung cancer cell activation. However, our data suggest 
the role of the asthmatic bronchial microenvironment and 
chronic inflammation in the formation and stabilization of 
the invasive front(s) of lung tumors. Accordingly, the potential 
mechanistic links between the asthmatic process and lung 
cancer progression justify the inclusion of asthma into the long 
list of potential prognostic markers in the lung cancer therapy.
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number of the transmigrated cells were counted following 24 h. Data are presented as the mean ± standard error of the mean of 3 independent experiments. 
*P<0.05 vs. A549 parameters in control medium. Note the infiltration of AS HBFs into A549 monolayers, accompanied by the chemotactic activity of the media 
from ‘open’ AS HBF/A549 co‑cultures and by the presence of scattered A549 within AS HBF continua. HBFs, human bronchial fibroblasts; AS, asthmatic 
donors; NA, non-asthmatic donors; α-SMA, α-smooth muscle actin; Cx43, connexin43; CM, conditional media.
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